Connect Biopharma Holdings (CNTB) Receivables - Other (2023 - 2025)
Connect Biopharma Holdings' Receivables - Other history spans 3 years, with the latest figure at $157000.0 for Q3 2025.
- For Q3 2025, Receivables - Other changed N/A year-over-year to $157000.0; the TTM value through Sep 2025 reached $157000.0, changed N/A, while the annual FY2024 figure was $262000.0, 25.36% down from the prior year.
- Receivables - Other for Q3 2025 was $157000.0 at Connect Biopharma Holdings, down from $193000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $351000.0 in Q4 2023 and bottomed at $157000.0 in Q3 2025.
- The 3-year median for Receivables - Other is $193000.0 (2025), against an average of $226000.0.
- The largest YoY upside for Receivables - Other was 25.36% in 2024 against a maximum downside of 25.36% in 2024.
- A 3-year view of Receivables - Other shows it stood at $351000.0 in 2023, then dropped by 25.36% to $262000.0 in 2024, then tumbled by 40.08% to $157000.0 in 2025.
- Per Business Quant, the three most recent readings for CNTB's Receivables - Other are $157000.0 (Q3 2025), $193000.0 (Q2 2025), and $167000.0 (Q1 2025).